CYLD and neoplasm: miR-362-5p was described as a tumor inducer in breast cancer [16], chronic myelocytic [17], and hepatocellular carcinoma [18] and its amplification, by releasing the promotion upon tumor-inhibiting genes such as CYLD and GADD45α, promotes tumorigenesis and metastasis.